113 related articles for article (PubMed ID: 33682616)
1.
Veena VK; Choudhury AR; Harikrishnan A
J Biomol Struct Dyn; 2022 Sep; 40(15):7018-7026. PubMed ID: 33682616
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Doshi JM; Tian D; Xing C
J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
[TBL] [Abstract][Full Text] [Related]
3. Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins.
Veena VK; Kennedy K; Lakshmi P; Krishna R; Sakthivel N
Mol Cell Biochem; 2016 Mar; 414(1-2):47-56. PubMed ID: 26833196
[TBL] [Abstract][Full Text] [Related]
4. Atranorin, an antimicrobial metabolite from lichen
Harikrishnan A; Veena V; Lakshmi B; Shanmugavalli R; Theres S; Prashantha CN; Shah T; Oshin K; Togam R; Nandi S
J Biomol Struct Dyn; 2021 Mar; 39(4):1248-1258. PubMed ID: 32096436
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax/Bcl-2 ratio and caspase-dependent apoptosis in colorectal cancer cell line.
Ahagh MH; Dehghan G; Mehdipour M; Teimuri-Mofrad R; Payami E; Sheibani N; Ghaffari M; Asadi M
Bioorg Chem; 2019 Dec; 93():103329. PubMed ID: 31590040
[TBL] [Abstract][Full Text] [Related]
6. Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis.
Doshi JM; Tian D; Xing C
Mol Pharm; 2007; 4(6):919-28. PubMed ID: 17874842
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
8. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
Manero F; Gautier F; Gallenne T; Cauquil N; Grée D; Cartron PF; Geneste O; Grée R; Vallette FM; Juin P
Cancer Res; 2006 Mar; 66(5):2757-64. PubMed ID: 16510597
[TBL] [Abstract][Full Text] [Related]
9. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
[TBL] [Abstract][Full Text] [Related]
10. Phenazine-1-carboxamide (PCN) from Pseudomonas sp. strain PUP6 selectively induced apoptosis in lung (A549) and breast (MDA MB-231) cancer cells by inhibition of antiapoptotic Bcl-2 family proteins.
Kennedy RK; Veena V; Naik PR; Lakshmi P; Krishna R; Sudharani S; Sakthivel N
Apoptosis; 2015 Jun; 20(6):858-68. PubMed ID: 25820140
[TBL] [Abstract][Full Text] [Related]
11. Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line.
Liu FT; Goff LK; Hao JH; Newland AC; Jia L
Apoptosis; 2004 May; 9(3):377-84. PubMed ID: 15258470
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
13. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.
Amarante-Mendes GP; Naekyung Kim C; Liu L; Huang Y; Perkins CL; Green DR; Bhalla K
Blood; 1998 Mar; 91(5):1700-5. PubMed ID: 9473236
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells.
Motyl T; Grzelkowska K; Zimowska W; Skierski J; Wareski P; Płoszaj T; Trzeciak L
Eur J Cell Biol; 1998 Apr; 75(4):367-74. PubMed ID: 9628323
[TBL] [Abstract][Full Text] [Related]
15. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
Jiang X; Tsang YH; Yu Q
Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
17. In vitro antitumor evaluation of 4H-chromene-3-carbonitrile derivatives as a new series of apoptotic inducers.
Saffari Z; Aryapour H; Akbarzadeh A; Foroumadi A; Jafari N; Farahnak Zarabi M; Farhangi A
Tumour Biol; 2014 Jun; 35(6):5845-55. PubMed ID: 24643681
[TBL] [Abstract][Full Text] [Related]
18. A novel peptide isolated from garlic shows anticancer effect against leukemic cell lines via interaction with Bcl-2 family proteins.
Rasaratnam K; Nantasenamat C; Phaonakrop N; Roytrakul S; Tanyong D
Chem Biol Drug Des; 2021 May; 97(5):1017-1028. PubMed ID: 33595876
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative.
Milanesi E; Costantini P; Gambalunga A; Colonna R; Petronilli V; Cabrelle A; Semenzato G; Cesura AM; Pinard E; Bernardi P
J Biol Chem; 2006 Apr; 281(15):10066-72. PubMed ID: 16481323
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of intracellular proapoptotic (Bax, Bak) and antiapoptotic (Bcl-2, Bcl-XL) proteins expression in thyrocytes from young patients with immune and non-immune thyroid disorders].
Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
Pediatr Endocrinol Diabetes Metab; 2007; 13(2):63-70. PubMed ID: 17880809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
